COCP - Company ID 0001412486
Cocrystal Pharma, Inc. trades as COCP. This page tracks Cocrystal Pharma, Inc. through 655 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Proxy materials | DEFA14A | 2026-05-27 |
| Proxy statement | DEF 14A | 2026-05-27 |
| Major company event | 8-K | 2026-05-26 |
| Quarterly report | 10-Q | 2026-05-15 |
| EFFECT | - | 2026-05-01 |
| Major company event | 8-K | 2026-04-30 |
| Securities registration | S-3 | 2026-04-23 |
| Major company event | 8-K | 2026-04-02 |
The largest companies sharing Cocrystal Pharma, Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Cocrystal Pharma, Inc. reported a net loss of $8.83M.